ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
72 hedge funds and large institutions have $146M invested in Adamas Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more funds holding
Funds holding: 64 → 72 (+8)
Holders
72
Holding in Top 10
2
Calls
$830K
Puts
$689K
Top Buyers
| 1 | +$24.6M | |
| 2 | +$12.5M | |
| 3 | +$10.6M | |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$7.13M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$6.41M |
Top Sellers
| 1 | -$3.69M | |
| 2 | -$1.53M | |
| 3 | -$1.53M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.2M |
| 5 |
DAM
Deltec Asset Management
New York
|
-$1.13M |